Innovation1 Biotech (IVBT) Financial Statements
Innovation1 Biotech Financial Overview
Innovation1 Biotech's market cap is currently $4.49K. The company's EPS TTM is $-0.30; its P/E ratio is 0.00; Innovation1 Biotech has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Aug 23 | Aug 22 | Aug 21 | Aug 20 | Aug 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 3.08K | $ 1.18K | $ 79.25K |
| Gross Profit | $ -52.70K | $ -2.55M | $ 1.66K | $ -1.78K | $ -50.09K |
| Operating Income | $ -1.37M | $ -5.25M | $ -258.44K | $ -217.00K | $ -627.00K |
| EBITDA | $ -5.68M | $ -38.33M | $ 1.26M | $ -1.28M | $ -168.00K |
| Net Income | $ -5.99M | $ -40.88M | $ 1.04M | $ -2.58M | $ -170.00K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 49.85K | $ 156.49K | $ 137.48K | $ 17.88K | $ 18.98K |
| Total Assets | $ 75.99K | $ 43.96M | $ 181.89K | $ 208.60K | $ 256.41K |
| Total Debt | $ 229.00K | $ 507.63K | $ 160.00K | $ 841.17K | $ 76.55K |
| Net Debt | $ 179.15K | $ 351.14K | $ 22.52K | $ 823.29K | $ 57.57K |
| Total Liabilities | $ 3.51M | $ 41.11M | $ 406.73K | $ 2.89M | $ 224.05K |
| Stockholders' Equity | $ -3.43M | $ 2.85M | $ -224.84K | $ -2.68M | $ 32.36K |
| Cash Flow | |||||
| Free Cash Flow | $ -620.20K | $ -3.13M | $ -30.41K | $ -410.25K | $ -782.49K |
| Operating Cash Flow | $ -620.20K | $ -3.13M | $ -30.41K | $ -410.25K | $ -775.93K |
| Investing Cash Flow | $ 0.00 | $ -853.14K | $ 0.00 | $ -300.00K | $ -6.56K |
| Financing Cash Flow | $ 513.56K | $ 4.00M | $ 150.00K | $ 709.15K | $ 27.00K |
Currency in USD
